HealthEquity Stock Falls on Disappointing Outlook | Global News Avenue

HealthEquity’s stock (Huaqingyuan) after Tuesday’s plunge Health Savings Account (HSA) The trustee’s outlook for next year fell short of expectations.

The company said it expects full-year revenue in fiscal 2026 to be US$1.275 billion to US$1.295 billion. Analysts surveyed by Visible Alpha are looking for a median range of $1.315 billion.

The lower-than-expected outlook offset HealthEquity’s strong third-quarter results, with earnings per share of 78 cents and revenue rising 21% year over year to $300.4 million. Both figures exceeded estimates.

Services revenue was $119.2 million, custody revenue was $141 million, and exchange revenue totaled $40.3 million. All three were up from the previous year.

The number of HSAs increased by 15% to 9.5 million, and total HSA assets increased by 33% to $30 billion. Total accounts, including HSAs and other consumer-directed benefits (CDBs), grew 8% to 16.5 million.

HealthEquity shares fell 5.6% to $95.39 on Tuesday, and despite Tuesday’s decline, they are up about 43% since the beginning of the year.

Correction – December 10, 2024: This article has been updated to correct an erroneous statement in HealthEquity’s forward guidance.